Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's experimental triple.
Viking Therapeutics Inc.'s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...
The European stock markets closed slightly higher in Thursday trading as the Stoxx Europe 600 rose 0.06%, the Swiss Market Index gained 0.21%, France's CAC increased 0.08%, the FTSE in London was up 0 ...